Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
Dublin, Aug. 13, 2019 (GLOBE NEWSWIRE) -- The "Global Electrocardiography Devices (ECG) Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. Technological advances ...
The company's products, HeartBeam AIMI and HeartBeam AIMIGo, are being developed with the aim of providing accurate diagnostic tools for heart attack detection anytime and anywhere. The core ...
Learn how ECG noise filtering that adapts to noise type improved QT and QRS accuracy and supports more reliable cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback